HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T Dörner Selected Research

Systemic Vasculitis

2/2013[Personalized medicine for rheumatoid arthritis : serological and clinical patient profiles to optimize B and T cell targeted therapy].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


T Dörner Research Topics

Disease

18Systemic Lupus Erythematosus (Libman-Sacks Disease)
04/2020 - 01/2000
16Autoimmune Diseases (Autoimmune Disease)
05/2020 - 09/2000
11Rheumatic Diseases (Rheumatism)
06/2020 - 01/2006
9Rheumatoid Arthritis
04/2020 - 06/2009
5Infections
04/2020 - 01/2000
4Connective Tissue Diseases (Connective Tissue Disease)
06/2020 - 01/2002
4Myositis (Idiopathic Inflammatory Myopathies)
02/2018 - 09/2000
3Vasculitis (Vasculitides)
02/2018 - 02/2018
3Non-Hodgkin Lymphoma (Lymphosarcoma)
02/2010 - 07/2008
2Psoriatic Arthritis
04/2020 - 07/2008
2Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
01/2019 - 05/2007
2Fever (Fevers)
02/2018 - 02/2018
2Communicable Diseases (Infectious Diseases)
12/2017 - 01/2000
2Hemolysis
06/2008 - 09/2003
2Lymphoma (Lymphomas)
12/2007 - 01/2006
2Congenital heart block
02/2005 - 09/2000
2Type 1 Hyper-IgM Immunodeficiency Syndrome
07/2001 - 06/2000
1Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
06/2020
1Autoimmune Hepatitis
06/2020
1Pregnancy Complications
05/2020
1Atopic Dermatitis (Atopic Eczema)
04/2020
1Ulcerative Colitis
04/2020
1Ankylosing Spondylitis
04/2020
1Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
02/2018
1Cryopyrin-Associated Periodic Syndromes
02/2018
1Adult-Onset Still's Disease
02/2018
1Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis)
02/2018
1Familial Mediterranean Fever (Periodic Disease)
02/2018
1Pemphigus (Pemphigus Vulgaris)
02/2018
1Diverticulitis
02/2018
1Dermatomyositis (Dermatopolymyositis)
02/2018
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2018
1Neoplasms (Cancer)
12/2017
1Multiple Sclerosis
03/2016
1Neuromyelitis Optica (Devic's Disease)
03/2016
1Fatigue
02/2016
1Castleman Disease (Castleman's Disease)
04/2014
1Inflammation (Inflammations)
04/2014
1Juvenile Arthritis (Juvenile Idiopathic Arthritis)
04/2014
1Proteinuria
10/2013
1Systemic Vasculitis
02/2013
1Chronic Disease (Chronic Diseases)
12/2011
1Necrosis
12/2011
1Immune System Diseases (Immune Disorders)
03/2011
1Progressive Multifocal Leukoencephalopathy
09/2010
1Psoriasis (Pustulosis Palmaris et Plantaris)
07/2008

Drug/Important Bio-Agent (IBA)

14AutoantibodiesIBA
09/2012 - 09/2000
12Rituximab (Mabthera)FDA Link
02/2018 - 12/2007
10Biological ProductsIBA
04/2020 - 12/2008
8AntibodiesIBA
06/2020 - 09/2000
5Pharmaceutical PreparationsIBA
06/2020 - 09/2003
4Tumor Necrosis Factor InhibitorsIBA
03/2014 - 09/2010
3CytokinesIBA
04/2020 - 09/2012
3EpitopesIBA
01/2018 - 02/2005
3Proteasome Endopeptidase Complex (Proteasome)IBA
05/2008 - 09/2000
3Immunoglobulin Variable RegionIBA
03/2005 - 09/2000
2Antinuclear AntibodiesIBA
06/2020 - 09/2000
2Antiphospholipid AntibodiesIBA
05/2020 - 05/2007
2Immunosuppressive Agents (Immunosuppressants)IBA
04/2020 - 04/2012
2AnticoagulantsIBA
01/2019 - 05/2007
2Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
02/2018 - 02/2018
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2018 - 03/2014
2Infliximab (Remicade)FDA Link
02/2018 - 01/2018
2Complement System Proteins (Complement)IBA
02/2016 - 10/2013
2Monoclonal AntibodiesIBA
02/2016 - 09/2010
2Immunoglobulins (Immunoglobulin)IBA
02/2016 - 04/2008
2Biomarkers (Surrogate Marker)IBA
11/2015 - 12/2011
2Glycoproteins (Glycoprotein)IBA
04/2014 - 05/2007
2AntigensIBA
09/2012 - 01/2006
2Immunoglobulin G (IgG)IBA
09/2010 - 03/2001
2Proteins (Proteins, Gene)FDA Link
02/2005 - 01/2002
1Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
05/2020
1baricitinibIBA
04/2020
1upadacitinibIBA
04/2020
1Antirheumatic Agents (DMARD)IBA
04/2020
1Janus Kinase InhibitorsIBA
04/2020
1GLPG0634IBA
04/2020
1peficitinibIBA
04/2020
1tofacitinibIBA
04/2020
1CT-P13IBA
01/2018
1DNA (Deoxyribonucleic Acid)IBA
02/2016
1SRI-5 (SRI 5)IBA
02/2016
1tabalumabIBA
02/2016
1Adrenal Cortex Hormones (Corticosteroids)IBA
02/2016
1Estrogens (Estrogen)FDA Link
02/2016
1B-Cell Activating FactorIBA
02/2016
1Interleukin-6 (Interleukin 6)IBA
04/2014
1tocilizumab (atlizumab)FDA Link
04/2014
1Genetic Markers (Genetic Marker)IBA
12/2011
1Vitamin DFDA LinkGeneric
03/2011
1Anti-Citrullinated Protein AntibodiesIBA
06/2009
1Protein-Arginine Deiminase Type 4IBA
06/2009
1cyclic citrullinated peptideIBA
06/2009

Therapy/Procedure

15Therapeutics
02/2018 - 01/2000
3Biological Therapy
02/2018 - 02/2018
1Secondary Prevention
05/2020
1Off-Label Use
02/2018
1Kidney Transplantation
02/2018
1Precision Medicine
02/2013
1Contraindications
09/2010